Eosinophilia in transgenic mice expressing interleukin 5

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• In vitro studies suggested Interleukin-5 (IL-5) primarily influences late-stage eosinophil differentiation.
• The role of other cytokines in generating eosinophil progenitor cells remained unclear.
• Understanding IL-5's in vivo function is crucial for immune response research.

Purpose of the Study:

• To investigate the in vivo effects of constitutive Interleukin-5 (IL-5) gene expression.
• To determine if IL-5 alone is sufficient for eosinophil differentiation.
• To assess the specificity of IL-5's action on hematopoietic lineages.

Main Methods:

• Generation of transgenic mice with a constitutively expressed genomic IL-5 gene fragment.
• Analysis of hematological parameters, including eosinophil, neutrophil, lymphocyte, and monocyte counts.
• Detection of IL-5 levels and mRNA expression in various tissues and serum.

Main Results:

• Transgenic mice exhibited significant splenomegaly and a marked increase in blood eosinophils (65- to 265-fold).
• IL-5 demonstrated relative specificity for the eosinophil lineage in vivo.
• Eosinophils infiltrated various tissues, including lungs, lymph nodes, and gut lamina propria.

Conclusions:

• Constitutive IL-5 gene induction is sufficient to produce eosinophilia in vivo.
• IL-5 can drive the complete pathway of eosinophil differentiation, challenging prior in vitro findings.
• IL-5's role in eosinophil development may extend beyond late-stage differentiation.